Abstract
Cyclodextrins are cyclic oligomers of glucose that can form water-soluble inclusion complexes with small molecules and portions of large compounds. These biocompatible, cyclic oligosaccharides do not elicit immune responses and have low toxicities in animals and humans. Cyclodextrins are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current cyclodextrin-based therapeutics are described and possible future applications discussed with particular focus on oral drug administration. This article focuses on development of in vitro reliable and simple prototypes for oral drug delivery by combing chemical, structural and pharmacological knowledge available to date in order to create an optimal oral drug delivery system based on modified cyclodextrins. Practical in vitro model is also demonstrated.
Keywords: Cyclodextrin, drug delivery systems, host-guest chemistry, in vitro models, hydrophilic drugs, carbamazepine/β-cyclodextrin, chromatographic separations, HP-β-cyclodextrin, SBE-β-cyclodextrin, β-cyclodextrin.
Current Organic Chemistry
Title:Cyclodextrins as Oral Drug Carrier Molecular Devices: Origins, Reasons and In-vitro Model Applications
Volume: 16 Issue: 20
Author(s): Victoria T. Perchyonok and Theunis Oberholzer
Affiliation:
Keywords: Cyclodextrin, drug delivery systems, host-guest chemistry, in vitro models, hydrophilic drugs, carbamazepine/β-cyclodextrin, chromatographic separations, HP-β-cyclodextrin, SBE-β-cyclodextrin, β-cyclodextrin.
Abstract: Cyclodextrins are cyclic oligomers of glucose that can form water-soluble inclusion complexes with small molecules and portions of large compounds. These biocompatible, cyclic oligosaccharides do not elicit immune responses and have low toxicities in animals and humans. Cyclodextrins are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current cyclodextrin-based therapeutics are described and possible future applications discussed with particular focus on oral drug administration. This article focuses on development of in vitro reliable and simple prototypes for oral drug delivery by combing chemical, structural and pharmacological knowledge available to date in order to create an optimal oral drug delivery system based on modified cyclodextrins. Practical in vitro model is also demonstrated.
Export Options
About this article
Cite this article as:
T. Perchyonok Victoria and Oberholzer Theunis, Cyclodextrins as Oral Drug Carrier Molecular Devices: Origins, Reasons and In-vitro Model Applications, Current Organic Chemistry 2012; 16 (20) . https://dx.doi.org/10.2174/138527212803520119
DOI https://dx.doi.org/10.2174/138527212803520119 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention
CNS & Neurological Disorders - Drug Targets The Blood-Brain Barrier as a Cause of Obesity
Current Pharmaceutical Design Cell Reprogramming: A New Chemical Approach to Stem Cell Biology and Tissue Regeneration
Current Pharmaceutical Biotechnology Mycotherapy of Cancer: An Update on Cytotoxic and Antitumor Activities of Mushrooms, Bioactive Principles and Molecular Mechanisms of their Action
Current Topics in Medicinal Chemistry Cellular Therapeutics for Chronic Wound Healing: Future for Regenerative Medicine
Current Drug Targets The Human Desmin Promoter Drives Robust Gene Expression for Skeletal Muscle Stem Cell-Mediated Gene Therapy
Current Gene Therapy Influence of Semax on the Level of Pro- and Anti-Inflammatory Cytokines in Conditions of "Social" Stress
Current Drug Therapy Polymeric Nanomicelles of Soluplus® as a Strategy for Enhancing the Solubility, Bioavailability and Efficacy of Poorly Soluble Active Compounds
Current Nanomedicine Cell Compatibility of an Eposimal Vector Mediated by the Characteristic Motifs of Matrix Attachment Regions
Current Gene Therapy Receptor-based 3D-QSAR in Drug Design: Methods and Applications in Kinase Studies
Current Topics in Medicinal Chemistry Peptidomics The Comprehensive Analysis of Peptides in Complex Biological Mixtures
Combinatorial Chemistry & High Throughput Screening Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers
Current Drug Targets A QSAR Study on Some Series of Anti-Hepatitis C Virus (HCV) Agents
Letters in Drug Design & Discovery A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression
Current Pharmaceutical Design Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma
Current Topics in Medicinal Chemistry Evaluation of Skin Permeability of Resveratrol Loaded Liposomes and Nanostructured Lipid Carriers using a Skin Mimic Artificial Membrane (skin-PAMPA)
Drug Delivery Letters Advances in Oncolytic Virus Therapy for Glioma
Recent Patents on CNS Drug Discovery (Discontinued) Non Steroidal Anti-Inflammatory and Anti-Allergy Agents
Current Medicinal Chemistry The Effects of Lipid-Regulating Therapy on Haemostatic Parameters
Current Pharmaceutical Design A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2
Current Drug Targets